不同增强后时间点对乳腺癌动态增强MRI T分期的影响
该回顾性研究纳入53例乳腺癌病灶的动态增强MRI检查,在轴位、冠状位和矢状位上于5个增强后时间点测量最大径。结果显示增强后时间点1测得的最大径与后续时间点显著不同,时间点3、4、5间无显著差异;轴位和矢状位时间点3、4、5以及冠状位所有时间点评估的MRI T分期与病理T分期无显著差异。结论认为MRI T分期受测量时间点显著影响,轴位和矢状位首选时间点3、4、5。
要点
- 乳腺癌动态增强MRI测量病灶最大径时,增强后时间点1的测值与后续时间点显著不同。
- 增强后时间点3、4、5之间测得的最大径无显著差异,为轴位和矢状位评估T分期的首选时间点。
- 冠状位所有时间点评估的MRI T分期均与病理T分期存在显著差异。
诊断标准与关键数值
- 轴位、冠状位和矢状位上,增强后时间点1测得的最大径与后续时间点相比差异显著(P < 0.0001)。
- 增强后时间点3、4、5之间测得的最大径无显著差异。
- 观察者内信度极好,ICC范围为0.915-0.992;观察者间信度极好,ICC范围为0.845-0.911。
- 轴位和矢状位增强后时间点1以及冠状位所有时间点评估的MRI T分期与病理T分期显著不同。
临床应用与阅片要点
- 在轴位和矢状位图像上,于增强后时间点3、4、5测量乳腺癌病灶最大径以评估MRI T分期。
- 避免在增强后时间点1测量最大径用于T分期,因其测值与后续时间点显著不同。
- 冠状位所有时间点评估的MRI T分期均与病理T分期显著不同,需谨慎用于T分期。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: to assess whether MRI T stage of breast cancer lesions (BCLs) is affected by maximum diameter (MD) measured at different post-contrast time points (TPs) on different acquisition planes on dynamic contrast-enhanced (DCE) MRI sequence.
METHODS: 53 DCE-MRI examinations of patients with BCLs were retrospectively selected. MD of BCLs was measured on axial, coronal and sagittal planes on DCE images at five different post-contrast TPs. Friedman test followed by Bonferroni-adjusted Wilcoxon-signed rank test for post-hoc analysis was performed to evaluate differences among the five measurements. Reliability of the measurements was evaluated with the intraclass correlation coefficient analysis. Differences between pathological and MRI T stage assessed at each TP on each acquisition plane were assessed using the Wilcoxon-sign rank test; p values <0.05 were considered statistically significant.
RESULTS: on axial, coronal and sagittal planes, MD measured at TP1 was significantly different (p < 0.0001) compared to those obtained at the subsequent TPs. No significant differences were found between MD measured at TPs 3, 4 and 5. Intra and inter-observer reliability resulted as very good, with ICC ranging between 0.915-0.992 and 0.845-0.911, respectively. MRI T stage assessed at TP1 on axial and sagittal plane as well as at all TPs on coronal plane was significantly different from pathological T stage.
CONCLUSION: MRI T stage definition of BCLs is significantly affected by the TP used for lesions' MD measurement. TPs 3, 4 and 5 are the preferred TPs for the assessment of MRI T stage of BCLs on both axial and sagittal planes.
引用
- Romeo V, Picariello V, Pignata A, et al. Influence of different post-contrast time points on dynamic contrast-enhanced (DCE) MRI T staging in breast cancer. Eur J Radiol. 2020. PMID: 31958631. doi:10.1016/j.ejrad.2020.108819
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。